A detailed history of Ten Capital Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ten Capital Wealth Advisors, LLC holds 3,490 shares of BMY stock, worth $201,582. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,490
Previous 1,455 139.86%
Holding current value
$201,582
Previous $100,000 123.0%
% of portfolio
0.07%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $129,649 - $143,955
2,035 Added 139.86%
3,490 $223,000
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $28,076 - $33,246
410 Added 39.23%
1,455 $104,000
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $110 - $65,237
849 Added 433.16%
1,045 $74,000
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $1,598 - $1,916
26 Added 15.29%
196 $14,000
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $10,524 - $11,461
170 New
170 $11,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ten Capital Wealth Advisors, LLC Portfolio

Follow Ten Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ten Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ten Capital Wealth Advisors, LLC with notifications on news.